CG
DVAX

Caprock Group’s Dynavax Technologies DVAX Stock Holding History

Caprock Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,277
Closed -$354K – 653
2022
Q4 		$354K Buy
33,277
+27
+0.1% +$314 0.03% 361
2022
Q3 		$347K Hold
33,250
– – 0.03% 364
2022
Q2 		$419K Buy
33,250
+8,250
+33% +$87.6K 0.04% 301
2022
Q1 		$271K Hold
25,000
– – 0.03% 458
2021
Q4 		$352K Buy
25,000
+13,000
+108% +$214K 0.03% 369
2021
Q3 		$231K Buy
+12,000
New +$159K 0.02% 460
2017
Q3 		– Sell
-13,890
Closed -$134K – 459
2017
Q2 		$134K Buy
+13,890
New +$90.2K 0.03% 401

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Caprock Group's DVAX Position: Q1 2023 in Review

Caprock Group sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 33,277 shares — an estimated $354K sold.

Caprock Group first reported a position in DVAX in Q2 2017 and held it in 7 quarters. The position peaked at $419K in Q2 2022. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • Caprock Group reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • Caprock Group sold 33,277 Dynavax Technologies shares in Q1 2023, an estimated $354K.
  • Caprock Group first reported a position in Dynavax Technologies in Q2 2017 and held it in 7 quarters.
  • Caprock Group's Dynavax Technologies position peaked at $419K in Q2 2022.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on Caprock Group's 13F filing for Q1 2023, filed 26 Apr 2023.